• Li Whye Cindy Ng, Sue Jenkins, and Kylie Hill.
• School of Physiotherapy and Curtin Health Innovation Research Institute, Curtin University, Perth, Western Australia.
• Disabil Rehabil. 2012 Jan 1; 34 (15): 1317-22.

PurposeTo evaluate the measurement properties of the StepWatch(™) Activity Monitor (SAM) and ActivPAL in COPD.MethodWhilst wearing both monitors, participants performed walking tasks at two self-selected speeds, with and without a rollator. Steps obtained using the monitors were compared with that measured by direct observation.ResultsTwenty participants aged 73 ± 9 years (FEV(1) = 35 ± 13% pred; 8 males) completed the study. Average speeds for the slow and normal walking tasks were 34 ± 7 m·min(-1)and 46 ± 10 m·min(-1), respectively. Agreement between steps recorded by the SAM with steps counted was similar irrespective of speed or rollator use (p = 0.63) with a mean difference and limit of agreement (LOA) of 2 steps·min(-1) and 6 steps·min(-1), respectively. Agreement for the ActivPAL was worse at slow speeds (mean difference 7 steps·min(-1); LOA 10 steps·min(-1)) compared with normal speeds (mean difference 4 steps·min(-1); LOA 5 steps·min(-1)) (p = 0.03), but was unaffected by rollator use. The change in step rate between slow and normal walking via direct observation was 12 ± 7 steps·min(-1) which was similar to that detected by the SAM (12 ± 6 steps·min(-1)) and ActivPAL (14 ± 7 steps·min(-1)).ConclusionsThe SAM can be used to detect steps in people who walk very slowly including those who use a rollator. Both devices were sensitive to small changes.

26 keywords...

hide…